Gene · 1829
Papers2,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation-Driven Remodeling of the Blood-Testis Barrier: Roles of Junctional Complexes, Actin Dynamics, and Kinase Signaling. | Biomedicines | 2026 | 41751322 | PubTator, text mining | PubMed |
| Distinct Modulation of Helicobacter pylori HtrA Activity by Divalent Transition Metals, Impacting HtrA Stability, Oligomerization and E-Cadherin Shedding. | Biomolecules | 2026 | 41750319 | PubTator, text mining | PubMed |
| Quantitative Histological Insights Into Sudden Arrhythmic Death Syndrome: Findings From a Forensic Autopsy Cohort. | APMIS | 2026 | 41747709 | PubTator, text mining | PubMed |
| Two δ-catenins, plakophilin 4 and p120, promote formation of distinct types of adherens junctions. | J Cell Biol | 2026 | 41746206 | PubTator, text mining | PubMed |
| Dentofacial Malocclusion and Salivary Biomarkers in Asthmatic Patients: A Scoping Review. | Int Dent J | 2026 | 41740246 | PubTator, text mining | PubMed |
| DSG2-Directed CAR-T Cells Safely and Universally Eliminate Solid Tumors. | Res Sq | 2026 | 41727586 | PubTator, text mining | PubMed |
| Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD. | Mol Ther Oncol | 2026 | 41716467 | PubTator, text mining | PubMed |
| Loss of junctional plakoglobin (JUP) activates PI3K/AKT signaling in head and neck squamous cell carcinoma. | Med Oncol | 2026 | 41712063 | PubTator, text mining | PubMed |
| DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer. | Adv Sci (Weinh) | 2026 | 41691490 | PubTator, text mining | PubMed |
| Desmoglein 2 (DSG2)-knockout human respiratory epithelial cell model to study species B adenovirus receptor usage. | Virol Sin | 2026 | 41679545 | PubTator, text mining | PubMed |
| Clinical features and outcome of arrhythmogenic cardiomyopathy because of a desmoglein-2 founder variant: A multicenter study. | Heart Rhythm | 2026 | 41662985 | PubTator, text mining | PubMed |
| Desmoglein-2 promotes the proliferation and invasion of lung adenocarcinoma cells by inhibiting anoikis through the activation of the integrin beta-1/focal adhesion kinase signaling pathway. | Am J Cancer Res | 2026 | 41657792 | PubTator, text mining | PubMed |
| Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma. | J Extracell Vesicles | 2026 | 41656939 | PubTator, text mining | PubMed |
| Integrative genomic and literature assessment of desmoglein 2-related arrhythmogenic cardiomyopathy with Italian cohort validation. | Commun Med (Lond) | 2026 | 41652012 | PubTator, text mining | PubMed |
| The desmoglein 2 interactome in primary neonatal cardiomyocytes. | J Cell Sci | 2026 | 41641743 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study Reveals Desmoglein-2 Predominance in Japanese Arrhythmogenic Cardiomyopathy. | J Arrhythm | 2026 | 41607864 | PubTator, text mining | PubMed |
| Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy. | Circ Heart Fail | 2026 | 41582809 | PubTator, text mining | PubMed |
| Early Onset Heart Failure due to RBM20 Variant: A Case Report Emphasizing Genetic Diagnosis and Arrhythmic Risk Stratification. | Clin Case Rep | 2026 | 41567528 | PubTator, text mining | PubMed |
| Desmoglein-2 dysregulation impairs epithelial barrier integrity in eosinophilic asthma. | Respir Res | 2026 | 41566510 | PubTator, text mining | PubMed |
| Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria? | Open Heart | 2026 | 41565355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1829/papers?page=3